Embolismo pulmonar(EP),Trombosis venosa profunda(TVP)e Ictus isquemico arterial o venoso(TSVC)son frecuentes en enfermos Covid severo. -Tx y/o prevención: heparina(HBPM) https://t.co/FCrr0Cbi0f. Estos casos se evitan con vacunación,incluida https://t.co/OM
RT @ClinMedJournals: #AIC #OpenAccess #Thrombotic/ #ischemic events in #COVID_19 patients with #ARDS https://t.co/BImqP3v4eS #FOAMEd #FOA…
RT @ClinMedJournals: #AIC #OpenAccess #Thrombotic/ #ischemic events in #COVID_19 patients with #ARDS https://t.co/BImqP3v4eS #FOAMEd #FOA…
#AIC #OpenAccess #Thrombotic/ #ischemic events in #COVID_19 patients with #ARDS https://t.co/BImqP3v4eS #FOAMEd #FOAMcc #ICU #circulatory #Coagulopathy #Thrombosis #pulmonary_embolism #Anticoagulation #ventilation #epidemics #infection #SARS_CoV_2 https
RT @La_SRLF: Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study, étude menée…
RT @La_SRLF: Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study, étude menée…
RT @La_SRLF: Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study, étude menée…
Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study, étude menée en France par le réseau CRICS-TRIGGERSEP vient d'être publiée dans #AIC (moins de TVP/EP sous ttt curatif) 👇 https://t.co/eluuFniZ
Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study Data from #RCT soon. #SRLF #AIC @La_SRLF https://t.co/Ursu2EpmbX